Article
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53
7 Jul 2020
Abstract excerpt
EBV, a human herpesvirus, is latently present in most nasopharyngeal carcinomas, Burkitt lymphomas, and some gastric cancers. To develop a lytic-induction therapy for treating patients with EBV-associated cancers, we need a way to efficiently reactivate EBV into lytic replication. EBV’s BZLF1 gene product, Zta, usually controls this reactivation switch. We previously showed that HIF-1α binds the BZLF1 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
